Clinical trials
Completed Phase 3 Gastrointestinal Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2005 | 1 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| AstraZeneca | 2 |
| Bausch Health Americas, Inc. | 2 |
| National Center for Research Resources (NCRR) | 2 |
| Abbott Nutrition | 1 |
| Astra USA | 1 |
| Chinese University of Hong Kong | 1 |
| FDA Office of Orphan Products Development | 1 |
| Furiex Pharmaceuticals, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Diseases | 30 |
| Digestive System Diseases | 12 |
| Gastroenteritis | 8 |
| Intestinal Diseases | 7 |
| Esophageal Diseases | 6 |
| Colonic Diseases | 5 |
| Eosinophilia | 5 |
| Eosinophilic Esophagitis | 5 |
| Esophagitis | 5 |
| Hypersensitivity | 5 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.